I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Daguenel, A.
52
results:
Search for persons
X
Format
Online (52)
Mediatypes
Articles (Online) (14)
OpenAccess-fulltext (38)
Languages
french (4)
english (48)
Sorted by: Relevance
Sorted by: Year
?
1
Amélioration de la qualité de vie sous leptine recombinante..:
Vatier, C.
;
Kalbasi, D.
;
Lascols, O.
...
Annales d'Endocrinologie. 78 (2017) 4 - p. 230-231 , 2017
Link:
https://doi.org/10.1016/..
?
2
One-year metreleptin therapy decreases PCSK9 serum levels i..:
Vatier, C.
;
Arnaud, L.
;
Prieur, X.
...
Diabetes & Metabolism. 43 (2017) 3 - p. 275-279 , 2017
Link:
https://doi.org/10.1016/..
?
3
Certification : participation de la pharmacie à la réalisat..:
Mille, F.
;
Daguenel, A.
;
Buyse, M.
..
Le Pharmacien Hospitalier et Clinicien. 49 (2014) 2 - p. e52 , 2014
Link:
https://doi.org/10.1016/..
?
4
L-04 Diminution de la prévalence des mutations de résistanc..:
Morand-Joubert, L.
;
Meynard, J.L.
;
Daguenel, A.
...
Médecine et Maladies Infectieuses. 38 (2008) - p. S164 , 2008
Link:
https://doi.org/10.1016/..
?
5
O-060 Routine once-weekly darbepoetin alfa administration i..:
Chouaid, C.
;
Borget, I.
;
Baud, M.
...
Lung Cancer. 49 (2005) - p. S23 , 2005
Link:
https://doi.org/10.1016/..
?
6
Therapeutic indications and metabolic effects of metrelepti..:
Mosbah, Héléna
;
Vantyghem, Marie‐Christine
;
Nobécourt, Estelle
...
Diabetes, Obesity and Metabolism. 24 (2022) 8 - p. 1565-1577 , 2022
Link:
https://doi.org/10.1111/..
?
7
Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in ..:
Otiniano, Armelle
;
van de Wyngaert, Zoe
;
Brissot, Eolia
...
Bone Marrow Transplantation. 58 (2022) 3 - p. 340-342 , 2022
Link:
https://doi.org/10.1038/..
?
8
Fecal microbiota transplantation to maintain remission in C..:
Saint-Antoine IBD Network
;
Sokol, Harry
;
Landman, Cecilia
...
Microbiome. 8 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1186/..
?
9
Adherence with metreleptin therapy and health self-percepti..:
Vatier, Camille
;
Kalbasi, Dina
;
Vantyghem, Marie-Christine
...
Orphanet Journal of Rare Diseases. 14 (2019) 1 - p. , 2019
Link:
https://doi.org/10.1186/..
?
10
34 MYRE: An e-learning system for radiotherapy:
Lavielle, J.B.
;
Carles, F.
;
Milhas, L.
..
Physica Medica. 56 (2018) - p. 54-55 , 2018
Link:
https://doi.org/10.1016/..
?
11
Evaluation of tolerability with the co-formulation elvitegr..:
Valin, Nadia
;
Fonquernie, Laurent
;
Daguenel, Anne
...
BMC Infectious Diseases. 16 (2016) 1 - p. , 2016
Link:
https://doi.org/10.1186/..
?
12
Routine once-weekly darbepoetin alfa administration is cost..:
Borget, Isabelle
;
Tilleul, Patrick
;
Baud, Mariette
...
Lung Cancer. 51 (2006) 3 - p. 369-376 , 2006
Link:
https://doi.org/10.1016/..
?
13
Therapeutic indications and metabolic effects of metrelepti..:
Mosbah, H
;
Vantyghem, M
;
Nobécourt, Estelle
...
info:eu-repo/semantics/altIdentifier/doi/10.1111/dom.14726. , 2022
Link:
https://hal.sorbonne-uni..
?
14
Therapeutic indications and metabolic effects of metrelepti..:
Mosbah, H
;
Vantyghem, M
;
Nobécourt, Estelle
...
info:eu-repo/semantics/altIdentifier/doi/10.1111/dom.14726. , 2022
Link:
https://hal.sorbonne-uni..
?
15
Therapeutic indications and metabolic effects of metrelepti..:
Mosbah, H
;
Vantyghem, M
;
Nobécourt, Estelle
...
info:eu-repo/semantics/altIdentifier/doi/10.1111/dom.14726. , 2022
Link:
https://hal.sorbonne-uni..
1-15